Official registry condition

Diabetes Mellitus, Type 1 peptide trials

8 selected ClinicalTrials.gov records carrying the official condition label Diabetes Mellitus, Type 1. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.

Registry records

8 selected records.

Connected peptides

5 profiles.

Registry update years

2021–2026 in selected records.

Indication intelligence

Selected evidence landscape

Trial phases3

Phase labels copied from the retained ClinicalTrials.gov versions.

Registry statuses3

Overall statuses at each retained observation, not necessarily current today.

Across the connected peptide profiles, PeptideScanner also carries 478 selected PubMed records and 19 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Diabetes Mellitus, Type 1 unless their own cited source says so.

Collection change ledger

Recently changed records on this condition hub

All recent changes →

These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.

Record added

ClinicalTrials.gov record NCT03216226

PeptideScanner retained ClinicalTrials.gov record NCT03216226 at 2026-11-16T01:42:39.027Z. Its registry update date was 2021-05-04, and PeptideScanner's reviewed identity mapping was dasiglucagon.

PeptideScanner change date
November 16, 2026
Cited source date
May 4, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03378635

PeptideScanner retained ClinicalTrials.gov record NCT03378635 at 2026-11-16T01:42:39.027Z. Its registry update date was 2021-06-10, and PeptideScanner's reviewed identity mapping was dasiglucagon.

PeptideScanner change date
November 16, 2026
Cited source date
June 10, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03688711

PeptideScanner retained ClinicalTrials.gov record NCT03688711 at 2026-11-16T01:42:39.027Z. Its registry update date was 2021-05-19, and PeptideScanner's reviewed identity mapping was dasiglucagon.

PeptideScanner change date
November 16, 2026
Cited source date
May 19, 2021
Evidence lane
Clinical trials

Attributed registry records

Selected records

All trial facets →